Diabeloop is a medical technology company focused on developing innovative solutions for the management of diabetes. Their flagship product, the DBLG1 System, is an automated solution for the management of Type 1 diabetes.

Diabeloop

We want to provide people living with diabetes with an intelligent therapeutic system to regulate blood glucose. This project was initiated in 2011 by the CERITD (Centre d’Études et de Recherches pour l’Intensification du Traitement du Diabète) in collaboration with the CEA LETI. After the success of the clinical trials in 2014, we created Diabeloop to bring the project to market and make it available to the largest number of people.Since spring 2021, DBLG1 System, the first automated insulin delivery device, is being marketed in several European countries: Germany, Italy, Spain, Switzerland, the Netherlands and France.

Bpifrance

EASME - EU Executive Agency for SMEs

Crédit Agricole

Sofimac Investment Managers

Air Liquide ALIAD

ODYSSEE VENTURE

KREAXI

Cemag Invest

Sofimac Innovation

Sud Rhone-Alpes Capital

Supernova Invest

Promontoires

Innovacom

LBO France

Terumo Corporation

UI Investissement

COM:DIABELOOP

Diabeloop